Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Molecular Medicine (Cambridge, Mass.)
|
June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types
Natalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Virchows Archiv : an International Journal of Pathology
|
February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types
Florian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
Scientific Reports
|
August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
Maximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One
|
June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
Ria Uhlig, Nina Bröker, Sören Weidemann, et al.
The American Journal of Surgical Pathology
|
August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types
Natalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One
|
April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
Seyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Virchows Archiv : an International Journal of Pathology
|
June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
Viktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Plos One
|
January 24, 2025
Correction: High prevalence of p16 staining in malignant tumors
Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Biomarker Research
|
December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples
Seyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology
|
January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
Florian Viehweger, Carola Böcker, Sören Weidemann, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Molecular Medicine (Cambridge, Mass.)
|
June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types
Natalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
Virchows Archiv : an International Journal of Pathology
|
February 17, 2026
Prevalence of KDM6A deficiency in human cancer: A tissue microarray study on 18,570 cancers from 153 different tumor types
Florian Viehweger, Paul Wirth, Natalia Gorbokon, et al.
Scientific Reports
|
August 9, 2023
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
Maximilian Lennartz, Henrietta Csomós, Viktoria Chirico, et al.
Plos One
|
June 28, 2023
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas
Ria Uhlig, Nina Bröker, Sören Weidemann, et al.
The American Journal of Surgical Pathology
|
August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types
Natalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Plos One
|
April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
Seyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Virchows Archiv : an International Journal of Pathology
|
June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
Viktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Plos One
|
January 24, 2025
Correction: High prevalence of p16 staining in malignant tumors
Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Biomarker Research
|
December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples
Seyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology
|
January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
Florian Viehweger, Carola Böcker, Sören Weidemann, et al.
Page
of 7